The two most promising ligands, RPS-040 and RPS-041, show excellent PSMA imaging characteristics based on their high specificity for PSMA, high tumor uptake and prolonged tumor retention, rapid clearance from non-target tissues and resulting high tumor-to-background ratios. The gene discussed is FOLH1; the disease is neoplasm.